Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) – Zacks Research lifted their Q3 2023 earnings estimates for Thermo Fisher Scientific in a report issued on Wednesday, September 20th. Zacks Research analyst R. Anand now anticipates that the medical research company will post earnings per share of $5.59 for the quarter, up from their prior forecast of $5.52. The consensus estimate for Thermo Fisher Scientific’s current full-year earnings is $22.37 per share. Zacks Research also issued estimates for Thermo Fisher Scientific’s Q3 2024 earnings at $6.35 EPS and FY2025 earnings at $27.76 EPS.
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) last released its quarterly earnings results on Wednesday, July 26th. The medical research company reported $5.15 earnings per share for the quarter, missing analysts’ consensus estimates of $5.43 by ($0.28). Thermo Fisher Scientific had a net margin of 13.14% and a return on equity of 18.59%. The firm had revenue of $10.69 billion for the quarter, compared to the consensus estimate of $10.99 billion. During the same period in the previous year, the business earned $5.51 earnings per share. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis.
View Our Latest Stock Analysis on Thermo Fisher Scientific
Thermo Fisher Scientific Stock Up 0.2 %
TMO opened at $502.51 on Friday. The firm has a market capitalization of $193.94 billion, a P/E ratio of 34.52, a PEG ratio of 2.38 and a beta of 0.77. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.42 and a quick ratio of 1.02. Thermo Fisher Scientific has a fifty-two week low of $475.77 and a fifty-two week high of $609.85. The company’s 50-day moving average is $539.06 and its 200 day moving average is $540.36.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in TMO. Silicon Valley Capital Partners bought a new position in Thermo Fisher Scientific in the 1st quarter worth $29,000. OLD Mission Capital LLC bought a new position in Thermo Fisher Scientific in the 4th quarter worth $31,000. Coppell Advisory Solutions LLC bought a new position in shares of Thermo Fisher Scientific in the 2nd quarter worth about $33,000. Live Oak Investment Partners bought a new position in shares of Thermo Fisher Scientific in the 4th quarter worth about $36,000. Finally, Tyler Stone Wealth Management bought a new position in shares of Thermo Fisher Scientific in the 2nd quarter worth about $37,000. 87.06% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Thermo Fisher Scientific
In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 14,100 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $550.00, for a total transaction of $7,755,000.00. Following the completion of the sale, the chief financial officer now directly owns 27,393 shares in the company, valued at $15,066,150. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 14,100 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $550.00, for a total transaction of $7,755,000.00. Following the completion of the sale, the chief financial officer now directly owns 27,393 shares in the company, valued at $15,066,150. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Marc N. Casper sold 10,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $549.00, for a total transaction of $5,490,000.00. Following the sale, the chief executive officer now owns 141,330 shares of the company’s stock, valued at $77,590,170. The disclosure for this sale can be found here. Insiders sold a total of 28,700 shares of company stock worth $15,799,270 over the last three months. 0.32% of the stock is owned by insiders.
Thermo Fisher Scientific Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 15th will be given a dividend of $0.35 per share. The ex-dividend date is Thursday, September 14th. This represents a $1.40 annualized dividend and a yield of 0.28%. Thermo Fisher Scientific’s payout ratio is presently 9.57%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Read More
- Five stocks we like better than Thermo Fisher Scientific
- How to Invest in Solar Energy
- 52-week Low Names To Tip The Upside Scale In Your Favor
- Mega Cap Stocks: What They Are and How to Invest
- KB Home Price Weakness is a Signal to Buy this Cash Machine
- What Is WallStreetBets and What Stocks Are They Targeting?
- Analysts Went All In On These Computer Stocks, Save Your Spot
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
